businesspress24.com - Cheoin Leisure Co., Ltd. Completes Acquisition of Units of Aurinia Pharmaceuticals Inc.
 

Cheoin Leisure Co., Ltd. Completes Acquisition of Units of Aurinia Pharmaceuticals Inc.

ID: 1444418

(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/29/16 -- Cheoin Leisure Co., Ltd. (the "Acquiror") is pleased to announce that it has acquired 1,694,915 units (the "Units") of Aurinia Pharmaceuticals Inc. ("Aurinia") under a previously announced private placement (the "Private Placement") at US$2.36 per Unit which, based on the June 22, 2016 Bank of Canada closing exchange rate of CDN$1.2839 per U.S. dollar, equals CDN$3.03 per Unit. Each Unit comprises one common share ("Common Share") in the capital of Aurinia and 0.35 of a Common Share purchase warrant (each whole such warrant, a "Warrant"), each such Warrant entitling the holder to purchase one Common Share.

Prior to the Private Placement, the Acquiror held nil Common Shares and Warrants representing 0% of the issued and outstanding Common Shares. After the Private Placement, the Acquiror holds 1,694,915 Common Shares and 593,220 Warrants representing beneficial ownership and control of 4.80% of the issued and outstanding Common Shares on a non-diluted basis and 5.05% of the outstanding Common Shares on a fully diluted basis.

Depending on market conditions and regulatory requirements, the Acquiror may from time to time increase or decrease its beneficial ownership, control or direction over any of Aurinia''s securities through market transactions, private agreements or otherwise. The Acquiror also announces that it has filed Form 62-103F1 - Required Disclosure Under the Early Warning Requirements as a result of its acquisition under the Private Placement, a copy of which can be obtained on Aurinia''s SEDAR profile at or by contacting the Acquiror.



Contacts:
Attention: Hannah Chung
+82-2-707-9359


Cheoin Leisure Co., Ltd.
15th floor ILJIN Bldg, 45
Mapodaero, Mapo-gu
Seoul, Korea



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
Flamel Technologies to Report Second Quarter 2016 Results
Bereitgestellt von Benutzer: Marketwired
Datum: 29.06.2016 - 09:47 Uhr
Sprache: Deutsch
News-ID 1444418
Anzahl Zeichen: 3690

contact information:
Contact person:
Town:

VANCOUVER, BRITISH COLUMBIA


Phone:

Kategorie:

Trials


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 799 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Cheoin Leisure Co., Ltd. Completes Acquisition of Units of Aurinia Pharmaceuticals Inc.
"
steht unter der journalistisch-redaktionellen Verantwortung von

Cheoin Leisure Co., Ltd. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Cheoin Leisure Co., Ltd.



 

Who is online

All members: 10 561
Register today: 2
Register yesterday: 2
Members online: 0
Guests online: 61


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.